News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb (BMY) Slaps Lawsuit On Biotech Pioneer Genentech (RHHBY) Over Cancer Immunotherapy Patents



7/27/2017 6:47:15 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Drug giant Bristol-Myers Squibb Co. filed suit Wednesday against biotech pioneer Genentech Inc., saying the South San Francisco company infringed patents in developing a potential blockbuster cancer immunotherapy drug.

Bristol-Myers Squibb (NYSE: BMY) seeks unspecified damages in the suit, filed in U.S. District Court in Delaware. At stake are sales of potentially billions of dollars worth of cancer drugs.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES